García de la Peña-Lefebvre Paloma, Chanseaud Youri, Tamby Mathieu C, Reinbolt Joseph, Batteux Frédéric, Allanore Yannick, Kahan André, Meyer Olivier, Benveniste Olivier, Boyer Olivier, Guillevin Loïc, Boissier Marie-Christophe, Mouthon Luc
UPRES EA 3408, UFR-SMBH Léonard-de-Vinci, Bobigny, France.
Clin Immunol. 2004 Jun;111(3):241-51. doi: 10.1016/j.clim.2004.01.005.
We have analyzed antibody (Ab) reactivities of patients with limited systemic sclerosis (SSc) and anti-centromere Ab, patients with diffuse SSc and anti-topoisomerase 1 (anti-topo 1) Ab, patients with diffuse SSc without anti-topo 1 or anti-centromere Ab and age- and gender-matched healthy controls with normal human tissue and endothelial cell (EC) antigens. IgG reactivities with tissue antigens differed significantly between patients with anti-topo 1 Ab and patients with anti-centromere Ab. One 100-kDa band identified as topoisomerase 1 in macrovascular and microvascular EC extracts was recognized by IgG from patients with anti-topo 1 Ab and 50% of patients without specific Ab. IgG from patients with limited SSc and anti-centromere Ab, but not those of other patients or controls specifically recognized a 80-kDa band only in microvascular EC. Our results indicate that Ab from patients with limited or diffuse SSc with or without anti-topo 1 Ab exhibit specific and mutually exclusive reactivity patterns.
我们分析了局限性系统性硬化症(SSc)合并抗着丝点抗体患者、弥漫性SSc合并抗拓扑异构酶1(抗拓扑异构酶1)抗体患者、无抗拓扑异构酶1或抗着丝点抗体的弥漫性SSc患者以及年龄和性别匹配的健康对照者针对正常人组织和内皮细胞(EC)抗原的抗体(Ab)反应性。抗拓扑异构酶1抗体患者与抗着丝点抗体患者的IgG与组织抗原的反应性存在显著差异。在大血管和微血管EC提取物中被鉴定为拓扑异构酶1的一条100 kDa条带,可被抗拓扑异构酶1抗体患者的IgG以及50%无特异性抗体患者的IgG识别。局限性SSc合并抗着丝点抗体患者的IgG,而非其他患者或对照者的IgG,仅在微血管EC中特异性识别一条80 kDa条带。我们的结果表明,有或无抗拓扑异构酶1抗体的局限性或弥漫性SSc患者的抗体呈现出特定且相互排斥的反应模式。